Greedy Gilead Sciences Raises Price Of Top Selling Products

What a nasty time to increase prices. The greedy bastards. They make more money than anyone on HIV. And they are still slow at providing access to the developing world for tenofovir so that people can switch from toxic Zerit and AZT. Shame on them.

Gilead Sciences Raises Price Of Top Selling Products

NEW YORK -(Dow Jones)- Gilead Sciences Inc. (GILD), known for selling 
HIV drugs, increased the prices of several of its top selling products 
at the beginning of the month.

The Foster City, Calif., drug maker increased the price of its biggest 
seller, HIV treatment Atripla, by 5.1%, according to a spokeswoman 
Monday. Gilead also raised the price of HIV drugs Truvada and Emtriva 
by 7.9%, and lung disease treatment Letairis by 4.9%.

For the company’s HIV products, a price freeze for AIDS Drug 
Assistance Programs remains in effect, she said.

Cowen & Co. analyst Phil Nadeau said the increases are “consistent in 
magnitude and timing with Gilead’s historical patterns.” He said the 
increases will impact about 60% to 70% of the U.S. market, which is 
about 60% of Gilead’s global sales of HIV drugs.

Gilead reported 2010 total product sales of $7.39 billion with Atripla 
bringing in $1.9 billion in the U.S.

Truvada had U.S. sales of $1.3 billion last year, while Emtriva had 
just $16.7 million. Letairis had 2010 sales of $240.3 million.

Leave a Comment

Your email address will not be published. Required fields are marked *